Claritas Pharmaceuticals, Inc.
CLAZF · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $4 |
| + Debt | $1 | $1 | $0 | $3 |
| Enterprise Value | $1 | $1 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$17 | $18 | -$15 |
| % Margin | – | – | – | – |
| Net Income | $4 | -$21 | $7 | -$32 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.16 | -1 | 0.64 | -5.2 |
| % Growth | 116% | -256.3% | 112.3% | – |
| Operating Cash Flow | -$0 | -$6 | -$5 | -$6 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$6 | -$5 | -$6 |